Novo Nordisk (NVO)

[behappyalways]

How $NVO makes money
https://x.com/Mayhem4Markets/status/1821873933919912300

[behappyalways]

Slimming drug sales in the United States "increased 15 times"
Novo Nordisk complains: problems with the medical insurance system

減肥藥賣到美國「飆15倍」 諾和諾德喊冤:醫保體制問題｜方念華｜FOCUS全球新聞 20240925 ‪@tvbsfocus‬

https://m.youtube.com/watch?v=ffu-XspdSOY

[behappyalways]

New Study Links Ozempic To Vision Loss, Confirms Harvard Research
https://www.zerohedge.com/medical/new-s ... d-research

[behappyalways]

Novo Nordisk Crashes Most On Record After CagriSema GLP-1 Results Disappoint
https://www.zerohedge.com/markets/novo- ... disappoint

[behappyalways]

Novo Shares Ignite After Next-Gen Shot Shows 22% Weight Loss
https://www.zerohedge.com/markets/novo- ... eight-loss

[behappyalways]

Novo Nordisk's Monthly Share Plunge Largest Since Dot Com Bust
https://www.zerohedge.com/political/nov ... t-com-bust

[behappyalways]

Novo Cuts Outlook, Pledges Crackdown On Copycat Obesity Drugs
https://www.zerohedge.com/markets/novo- ... -hit-sales

[behappyalways]

How Novo Nordisk makes money
https://x.com/Mayhem4Markets/status/1921253324298272973

[winston]

vested

Reaction to new Novo Nordisk CEO, profit warning

[Source: Reuters

https://www.investing.com/news/stock-ma ... ng-4157645

[winston]

vested

Novo Nordisk: Why Is the Stock Falling Over 20% Today?

By Timothy Fries

Second forecast cut of 2025.

The obesity drugmaker warned that both full-year sales and operating profit would grow significantly less than previously expected, citing weaker demand projections for its blockbuster weight-loss drug Wegovy and diabetes treatment Ozempic.

The company now expects sales growth of just 8%-14% in local currencies.

Operating profit growth projections were similarly downgraded to 10%-16%.

The company cited “lower growth expectations for Wegovy in the U.S. obesity market” and “lower growth expectations for Ozempic in the U.S. GLP-1 diabetes market” as primary drivers of the reduced outlook.

Source: investing.com

https://www.investing.com/analysis/novo ... -200664509